The Supreme Court's decision to strike down President Trump's reciprocal tariffs doesn't end his plans for pharmaceutical industry tariffs. Join us now. A former FDA commissioner uh Dr.. Scott Gotautle. He's a CNBC contributor. Serves on the boards of Aluminina, Fizer, and United Health. You you're not so sure, are you? Doesn't the pharmaceutical industry agreed to a lot of what uh the president wanted? and and are are future tariffs necessary at this point for for where President Trump wanted to go with wi ...

Trade Policy and Market Reactions - President Trump announced a significant reduction in U.S. tariffs on Indian goods from 50% to 18%, leading to a surge in Indian equity markets, with the Nifty 50 index rising 4.86% and the BSE Sensex increasing by 4.48% [2] - U.S.-listed Indian companies such as Infosys, Wipro, and HDFC Bank experienced notable stock increases of 4.3%, 6.8%, and 4.4% respectively, while the iShares MSCI India ETF saw a 3% rise [2] - The announcement of new tariffs on U.S. imports from countries trading with Iran could reach as high as 25%, raising concerns about market volatility, particularly for energy producers and sectors like airlines [3] Domestic Initiatives and Market Impact - An executive order was signed to increase the in-quota tariff-rate quota for lean beef trimmings by 80,000 metric tons for 2026, aimed at reducing ground beef prices, which averaged $6.69 per pound in December 2025 [4] - The TrumpRx.gov website was launched to provide discounted drugs, with Pfizer's stock rising 6.8% following its announcement to participate, offering an average 50% discount on certain drugs [5][6] - Analysts expressed skepticism about the effectiveness of TrumpRx, with some labeling it a "glorified coupon book" and suggesting it may not significantly impact consumer behavior [6][7] Market Performance and Economic Indicators - The Dow Jones Industrial Average (DJIA) reached a new all-time high of 50,115.67, following a significant rally of 1,207 points, while the broader market saw a rebound with the S&P 500 and Nasdaq also gaining [8][9] - Despite the rally, the S&P 500 and Nasdaq ended the week slightly down, indicating ongoing concerns about AI spending and aggressive tech selling [9] - Economic studies suggest that Trump's tariffs may slow economic growth, with U.S. consumers expected to bear 67% of the tariff burden by July 2026, translating to an average tax increase of $1,300 per household [10]